BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
· Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase..
*GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) *announces that its..